Please login to the form below

Not currently logged in


This page shows the latest BNT162b2 news and features for those working in and with pharma, biotech and healthcare.

Pfizer and BioNTech initiate phase 2 study of ‘enhanced’ COVID-19 vaccine

Pfizer and BioNTech initiate phase 2 study of ‘enhanced’ COVID-19 vaccine

overcome the relatively short-lived immune response seen with their first-generation vaccine, BNT162b2.

Latest news

More from news
Approximately 8 fully matching, plus 60 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Environment: where does the pharmaceutical industry stand?
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...